• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Amendment: SEC Form SC 13G/A filed by Cross Country Healthcare Inc.

    11/13/24 9:39:57 PM ET
    $CCRN
    Professional Services
    Consumer Discretionary
    Get the next $CCRN alert in real time by email
    SC 13G/A 1 ccrn1124.txt SCHEDULE 13G Amendment No. 1 Name of Issuer: Cross Country Healthcare, Inc. Title of Class of Securities: Common Stock CUSIP Number: 227483104 Item 1: Reporting Person: Wasatch Advisors LP 87-0319391 Item 2: Check Box If Member of Group: Not Applicable Item 3: SEC Use Item 4: Place of Organization: Utah Items 5-8: Number of Shares Owned With: Item 5: Sole Voting Power: 0 Item 6: Shared Voting Power: 0 Item 7: Sole Dispositive Power: 0 Item 8: Shared Dispositive Power: 0 Item 9: Aggregate Amount Owned: 0 Item 10: Check Box If Aggregate Amount Excludes Certain Shares: N/A Item 11: Percent of Class Owned: 0% Item 12: Type of Reporting Person: IA Item 1(a): Name of Issuer: Cross Country Healthcare, Inc. Item l(b): Address of Issuer: 6551 Park of Commerce Boulevard, N.W., Boca Raton, FL 33487 Item 2(a): Name of Person Filing: Wasatch Advisors LP Item 2(b): Address: 505 Wakara Way, Salt Lake City, UT 84108 Item 2(c): Citizenship: Not Applicable Item 2(d): Title of Class of Securities: Common Stock Item 2(e): CUSIP Number: 227483104 Item 3(e): Investment Adviser registered under section 203 of the Investment Advisers Act of 1940 Item 4(a): Amount Owned: 0 Item 4(b): Percent of Class Owned: 0% Item 4(c)(i): Sole Voting Power: 0 Item 4(c)(ii): Shared Voting Power: 0 Item 4(c)(iii): Sole Dispositive Power: 0 Item 4(c)(iv): Shared Dispositive Power: 0 Item 5: Check Box If Ownership Is 5% or Less of Class: [X] Item 6. Ownership of More Than 5% on Behalf of Another Person: N/A Item 7: Identification of Subsidiary: Not Applicable Item 8: Identification of Members of Group: Not Applicable Item 9: Notice of Dissolution of Group: Not Applicable Item 10: Certification: By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired in the ordinary course of business and were not acquired for the purpose of and do not have the effect of changing or influencing the control of the issuer of such securities and were not acquired in connection with or as a participant in any transaction having such purpose or effect. SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct as of September 30, 2024. Date: 11/13/24 Signature: /s/JB Taylor Name/Title: JB Taylor/CEO
    Get the next $CCRN alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $CCRN

    DatePrice TargetRatingAnalyst
    12/10/2024Outperform → Mkt Perform
    Barrington Research
    12/6/2023Mkt Perform
    JMP Securities
    11/3/2023$32.00 → $21.00Buy → Hold
    Jefferies
    6/26/2023Outperform
    William Blair
    3/10/2023$30.00Buy
    Loop Capital
    10/5/2022$36.00Buy → Hold
    Truist
    2/24/2022$33.00 → $42.00Buy
    Benchmark
    1/27/2022$18.00 → $27.00Hold → Buy
    Jefferies
    More analyst ratings

    $CCRN
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Cross Country downgraded by Barrington Research

      Barrington Research downgraded Cross Country from Outperform to Mkt Perform

      12/10/24 9:21:19 AM ET
      $CCRN
      Professional Services
      Consumer Discretionary
    • JMP Securities initiated coverage on Cross Country

      JMP Securities initiated coverage of Cross Country with a rating of Mkt Perform

      12/6/23 7:33:30 AM ET
      $CCRN
      Professional Services
      Consumer Discretionary
    • Cross Country downgraded by Jefferies with a new price target

      Jefferies downgraded Cross Country from Buy to Hold and set a new price target of $21.00 from $32.00 previously

      11/3/23 7:41:51 AM ET
      $CCRN
      Professional Services
      Consumer Discretionary